SCIASCIA THOMAS - Insider Non-Derivative Transactions at Trevi Therapeutics, Inc. (TRVI) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Aug 19, 2024, SCIASCIA THOMAS's relationship to Trevi Therapeutics, Inc. (TRVI) is Officer (Chief Scientific Officer), and currently has 236,811 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other TRVI insiders.
Data Source: SEC.
SCIASCIA THOMAS - Insider Non-Derivative Transactions of TRVI Common Stock
SCIASCIA THOMAS - Insider Non-Derivative Transactions at TRVI
Items per page:
0 of 0
Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
---|---|---|---|---|
Aug 20, 2024 | Sell -- (Common Stock) | 16496 | 2.96 | 220315 |
Aug 20, 2024 | M -- (Common Stock) | 16496 | 1.43 | 236811 |
Aug 17, 2024 | Sell -- (Common Stock) | 18660 | 2.76 | 220315 |
Aug 17, 2024 | M -- (Common Stock) | 18660 | 1.43 | 238975 |
Aug 16, 2024 | Sell -- (Common Stock) | 12745 | 2.79 | 220315 |
Aug 16, 2024 | M -- (Common Stock) | 12745 | 1.43 | 233060 |
Aug 15, 2024 | Sell -- (Common Stock) | 100 | 2.75 | 220315 |
Aug 15, 2024 | M -- (Common Stock) | 100 | 1.43 | 220415 |
May 30, 2024 | Sell -- (Common Stock) | 53368 | 2.55 | 214433 |
May 30, 2024 | M -- (Common Stock) | 59354 | 2.19 | 267801 |